Bitcoin set for a rebound that could stretch toward $100000, BTIG says
Medpace Holdings, Inc. NASDAQ:MEDP Chief Financial Officer (CFO) and Treasurer Kevin M. Brady, recently sold 3,000 shares of common stock at prices ranging from $590.00 to $590.72, totaling approximately $1.77 million. The sale occurred with Medpace trading near its 52-week high of $625, with the stock currently valued at $611.81. According to InvestingPro data, Medpace has shown strong momentum with an 83% return over the past year.
According to a Form 4 filing with the Securities and Exchange Commission, the transactions occurred on November 21, 2025. On the same day, Brady exercised options to acquire 3,000 shares of Medpace Holdings common stock at a price of $166.73, for a total value of $500,189. The clinical research organization currently has a market capitalization of $17.23 billion and trades at a P/E ratio of 42.84, reflecting its premium valuation.
The filing also indicates that Brady gifted 170 shares of common stock to a donor-advised fund.
Following these transactions, Brady directly owns 5,830 shares of Medpace Holdings, Inc.
In other recent news, Medpace Holdings reported impressive third-quarter 2025 earnings, exceeding market expectations. The company achieved an earnings per share (EPS) of $3.86, surpassing the forecasted $3.53. Revenue also outperformed projections, reaching $659.9 million compared to the anticipated $640.99 million. Additionally, Truist Securities raised its price target for Medpace from $436.00 to $555.00, maintaining a Hold rating. This adjustment followed discussions between Truist Securities and Medpace’s management regarding performance metrics and future outlook. These developments highlight the company’s strong financial performance and positive analyst sentiment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.